http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8501993-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D461-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1985-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1e9b1ebca5d78d685a9ee278cd7437a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b50ad09f6af267f21b2051fe77313d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e3aee379340966f9c233ddf691659f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f55022a0cdb16099983b5f8c9666fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99aa80d6685e50c6bca3bcde46497004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a08c79fbdfd8cf3126d6fdc8e621534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bf1be5380d15177d66dfd0d63d3fac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44828bc30fdb1a06bdc656e713b4e0bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be96aa9c2265146b2a50a0913c83830
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de5f78b3d3a355cfca5f79ff2eac64e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8632db9b7483da6bcaaddeb6a230bac5
publicationDate 1985-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8501993-D0
titleOfInvention NEW APOVINCAMINOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract The invention relates to new apovincaminol derivatives of the formula /I/ <IMAGE> (I) wherein R1 is hydrogen, nitro or halogen, R2 is a substituted or unsubstituted alkyl or phenyl group, R3 and R4 together form a valency bond or each independently represents hydrogen, hydroxyl or an -OR5 group, in which R5 is substituted or unsubstituted alkanoyl or benzoyl group, with the proviso that if R2 stands for a 3,4,5-trimethoxyphenyl group and R1 is hydrogen, R3 and R4 together do not form a valency bond, or if R2 is a 3,4,5-trimethoxyphenyl group and R3 and R4 both are hydrogen, R1 is other than hydrogen, nitro or bromine, and acid addition salts thereof. The compounds may be used in the therapy of various skin diseases accompanied by a pathological cell proliferation, preferably psoriasis.
priorityDate 1984-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587

Total number of triples: 35.